Last Updated: November 10, 2026

Chartwell Rx Company Profile

« Back to Dashboard

What is the competitive landscape for CHARTWELL RX

CHARTWELL RX has four hundred and ninety-seven approved drugs.

There are two tentative approvals on CHARTWELL RX drugs.

Summary for Chartwell Rx

US Patents:	0
Tradenames:	348
Ingredients:	327
NDAs:	497

Drugs and US Patents for Chartwell Rx

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Chartwell Rx	PIOGLITAZONE HYDROCHLORIDE	pioglitazone hydrochloride	TABLET;ORAL	076798-003	Oct 26, 2012	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Chartwell Rx	THIOTHIXENE	thiothixene	CAPSULE;ORAL	070602-001	Jun 5, 1987		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Chartwell Rx	TIZANIDINE HYDROCHLORIDE	tizanidine hydrochloride	TABLET;ORAL	076280-001	Nov 26, 2002		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Chartwell Rx	LOSARTAN POTASSIUM	losartan potassium	TABLET;ORAL	077424-003	Oct 6, 2010	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Chartwell Rx	SILODOSIN	silodosin	CAPSULE;ORAL	204726-001	Mar 31, 2017	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Chartwell Rx	TRIAMCINOLONE ACETONIDE	triamcinolone acetonide	CREAM;TOPICAL	208763-003	Feb 1, 2017	AT	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Chartwell Rx

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Chartwell Rx	TAZORAC	tazarotene	GEL;TOPICAL	020600-002	Jun 13, 1997	5,089,509	⤷ Start Trial
Chartwell Rx	AVAGE	tazarotene	CREAM;TOPICAL	021184-003	Sep 30, 2002	5,089,509	⤷ Start Trial
Chartwell Rx	TAZORAC	tazarotene	GEL;TOPICAL	020600-001	Jun 13, 1997	5,089,509	⤷ Start Trial
Chartwell Rx	MOBAN	molindone hydrochloride	TABLET;ORAL	017111-006	Approved Prior to Jan 1, 1982	3,491,093	⤷ Start Trial
Chartwell Rx	VELTIN	clindamycin phosphate; tretinoin	GEL;TOPICAL	050803-001	Jul 16, 2010	5,690,923	⤷ Start Trial
Chartwell Rx	LIMBITROL	amitriptyline hydrochloride; chlordiazepoxide	TABLET;ORAL	016949-001	Approved Prior to Jan 1, 1982	4,316,897	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.